| Madeline Adams Dillon, MD | |
|
1415 Rolkin Ct, Suite 102, Charlottesville, VA 22911-3642 | |
| (434) 951-2191 | |
| (434) 977-0200 |
| Full Name | Madeline Adams Dillon |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 20 Years |
| Location | 1415 Rolkin Ct, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043428410 | NPI | - | NPPES |
| VAA102934 | Other | VA | MEDICARE PTAN |
| 1043428410 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 0101241904 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy Partners Pllc | 7113822420 | 149 |
News Archive
The Senate Health, Education, Labor and Pensions Committee likely will pass legislation that would require health insurance companies to cover mental illnesses at the same level as they cover physical illnesses, committee Chair Edward Kennedy (D-Mass.) said, CQ HealthBeat reports.
The U.S. Food and Drug Administration (FDA) has amped up its warnings against popular herbal drug kratom. The new warning mentions the deadly risks associated with kratom including a case of a teenager who hanged himself under influence.
It is estimated that during a heart attack, one billion cells in the heart are lost. In the wake of the heart attack, the lost tissue is replaced by scar tissue, which can lead to heart failure, arrhythmia and death. In a new study, researchers from the University of Tsukuba have shown how cells in the scar tissue can be converted to heart muscle cells, effectively regenerating the injured heart.
According to a new study published in the Journal of the Royal Society of Medicine, the carbon footprint of personal protective equipment (PPE) provided to health and social care staff in England during the first six months of the COVID-19 pandemic was equivalent to flying from London to New York 244 times every day.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today results from the two-year Phase III ALLEGRO study of laquinimod, an oral, once-daily, investigational immunomodulator for the treatment of relapsing forms of multiple sclerosis (MS). These data will be presented as late-breaking research at the Annual Meeting of the American Academy of Neurology (AAN).
› Verified 7 days ago
| Entity Name | Allergy Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740416247 PECOS PAC ID: 7113822420 Enrollment ID: O20091030000066 |
News Archive
The Senate Health, Education, Labor and Pensions Committee likely will pass legislation that would require health insurance companies to cover mental illnesses at the same level as they cover physical illnesses, committee Chair Edward Kennedy (D-Mass.) said, CQ HealthBeat reports.
The U.S. Food and Drug Administration (FDA) has amped up its warnings against popular herbal drug kratom. The new warning mentions the deadly risks associated with kratom including a case of a teenager who hanged himself under influence.
It is estimated that during a heart attack, one billion cells in the heart are lost. In the wake of the heart attack, the lost tissue is replaced by scar tissue, which can lead to heart failure, arrhythmia and death. In a new study, researchers from the University of Tsukuba have shown how cells in the scar tissue can be converted to heart muscle cells, effectively regenerating the injured heart.
According to a new study published in the Journal of the Royal Society of Medicine, the carbon footprint of personal protective equipment (PPE) provided to health and social care staff in England during the first six months of the COVID-19 pandemic was equivalent to flying from London to New York 244 times every day.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today results from the two-year Phase III ALLEGRO study of laquinimod, an oral, once-daily, investigational immunomodulator for the treatment of relapsing forms of multiple sclerosis (MS). These data will be presented as late-breaking research at the Annual Meeting of the American Academy of Neurology (AAN).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Madeline Adams Dillon, MD Po Box 603725, Charlotte, NC 28260-3725 Ph: (828) 575-2625 | Madeline Adams Dillon, MD 1415 Rolkin Ct, Suite 102, Charlottesville, VA 22911-3642 Ph: (434) 951-2191 |
News Archive
The Senate Health, Education, Labor and Pensions Committee likely will pass legislation that would require health insurance companies to cover mental illnesses at the same level as they cover physical illnesses, committee Chair Edward Kennedy (D-Mass.) said, CQ HealthBeat reports.
The U.S. Food and Drug Administration (FDA) has amped up its warnings against popular herbal drug kratom. The new warning mentions the deadly risks associated with kratom including a case of a teenager who hanged himself under influence.
It is estimated that during a heart attack, one billion cells in the heart are lost. In the wake of the heart attack, the lost tissue is replaced by scar tissue, which can lead to heart failure, arrhythmia and death. In a new study, researchers from the University of Tsukuba have shown how cells in the scar tissue can be converted to heart muscle cells, effectively regenerating the injured heart.
According to a new study published in the Journal of the Royal Society of Medicine, the carbon footprint of personal protective equipment (PPE) provided to health and social care staff in England during the first six months of the COVID-19 pandemic was equivalent to flying from London to New York 244 times every day.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today results from the two-year Phase III ALLEGRO study of laquinimod, an oral, once-daily, investigational immunomodulator for the treatment of relapsing forms of multiple sclerosis (MS). These data will be presented as late-breaking research at the Annual Meeting of the American Academy of Neurology (AAN).
› Verified 7 days ago
Dr. Michael R Nelson, M.D.,PH.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2955 Ivy Rd Ste 311, Charlottesville, VA 22903 Phone: 434-924-2227 Fax: 434-244-4503 | |
Gary Paige Rakes, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1415 Rolkin Ct, Suite 102, Charlottesville, VA 22911 Phone: 434-951-2191 Fax: 434-977-0200 | |
Larry Borish, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: Lee St, Charlottesville, VA 22908 Phone: 434-924-0000 | |
Mrs. Christina Funari Ortiz, M.D., M.P.H. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Box 800386, Charlottesville, VA 22908 Phone: 434-924-2533 Fax: 434-243-2628 | |
Thomas A.e. Platts Mills, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: Hospital Drive, 5th Floor, Charlottesville, VA 22903 Phone: 434-924-2227 Fax: 434-924-5779 | |
Dr. Arvind Madaan, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1532 Insurance Ln, Charlottesville, VA 22911 Phone: 434-295-2727 Fax: 434-295-2777 |